Literature DB >> 9722069

Patterns of gonadal dysfunction following bone marrow transplantation.

A C Mertens1, N K Ramsay, S Kouris, J P Neglia.   

Abstract

We reviewed gonadal function in 270 patients who underwent bone marrow transplantation (BMT) between 1974 and 1988. Age at transplant ranged from 6 to 54 years (mean 25.6 years). Diagnoses included acute myelogenous leukemia, chronic myelogenous leukemia, aplastic anemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, Hodgkin's disease and other diagnoses. Effects of patient characteristics on risk of gonadal dysfunction were analyzed by comparing the cumulative probability of developing gonadal dysfunction over time from BMT. Ninety-two percent of the males and 99% of the females developed evidence of gonadal dysfunction. Females were not only more likely to develop elevated gonadotrophin levels than males, but did so earlier after BMT. Odds ratios were calculated to determine potentially important prognostic factors for the development of an elevated gonadotrophin level. Older age at BMT was correlated with an increased risk in the development of elevated gonadotrophin levels. Individuals who received radiation were more likely to develop an elevated FSH level over time than those who had received no preparative radiation treatment. Males were more likely to experience gonadal recovery than females. In those cases that did recover, males tended to recover more quickly after BMT than females.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722069     DOI: 10.1038/sj.bmt.1701342

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  18 in total

1.  Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Can-Lan Sun; Liton Francisco; Toana Kawashima; Wendy Leisenring; Leslie L Robison; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

2.  Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies.

Authors:  Umberto Ricardi; Andrea Riccardo Filippi; Eleonora Biasin; Patrizia Ciammella; Angela Botticella; Pierfrancesco Franco; Andrea Corrias; Elena Vassallo; Riccardo Ragona; Franca Fagioli
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

3.  Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

Authors:  Catherine J Lee; Soyoung Kim; Heather R Tecca; Stephanie Bo-Subait; Rachel Phelan; Ruta Brazauskas; David Buchbinder; Betty K Hamilton; Minoo Battiwalla; Navneet S Majhail; Hillard M Lazarus; Peter J Shaw; David I Marks; Mark R Litzow; Saurabh Chhabra; Yoshihiro Inamoto; Zachariah DeFilipp; Gerhard C Hildebrandt; Richard F Olsson; Kimberly A Kasow; Jane L Liesveld; Seth J Rotz; Sherif M Badawy; Neel S Bhatt; Jean A Yared; Kristin M Page; Martha L Arellano; Michael Kent; Nosha Farhadfar; Sachiko Seo; Peiman Hematti; César O Freytes; Alicia Rovó; Siddhartha Ganguly; Sunita Nathan; Linda Burns; Bronwen E Shaw; Lori S Muffly
Journal:  Blood Adv       Date:  2020-03-24

4.  Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Alicia Rovó; Mahmoud Aljurf; Sandra Chiodi; Simonetta Spinelli; Nina Salooja; Gülsan Sucak; Ann Hunter; Tan Swee Kim; Gérard Socié; Maria Teresa van Lint; Jakob R Passweg; Mutlu Arat; Manuela Badoglio; André Tichelli
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

5.  Dynamics of fertility impairment in childhood brain tumour survivors.

Authors:  C Pfitzer; C-M Chen; T Wessel; T Keil; A Sörgel; T Langer; D Steinmann; A Borgmann-Staudt
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-20       Impact factor: 4.553

6.  Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.

Authors:  R Phelan; E Mann; C Napurski; T E DeFor; A Petryk; W P Miller; J E Wagner; M R Verneris; A R Smith
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

7.  Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.

Authors:  B Frey Tirri; P Häusermann; H Bertz; H Greinix; A Lawitschka; C-P Schwarze; D Wolff; J P Halter; D Dörfler; R Moffat
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

8.  Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.

Authors:  G Massenkeil; T Alexander; O Rosen; B Dörken; G Burmester; A Radbruch; F Hiepe; R Arnold
Journal:  Rheumatol Int       Date:  2016-08-13       Impact factor: 2.631

9.  Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study.

Authors:  C Pfitzer; H Orawa; M Balcerek; T Langer; U Dirksen; P Keslova; N Zubarovskaya; F R Schuster; A Jarisch; G Strauss; A Borgmann-Staudt
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-01       Impact factor: 4.553

10.  Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models.

Authors:  Kourosh Sayehmiri; Mohammad R Eshraghian; Kazem Mohammad; Kamran Alimoghaddam; Abbas Rahimi Foroushani; Hojjat Zeraati; Banafsheh Golestan; Ardeshir Ghavamzadeh
Journal:  J Exp Clin Cancer Res       Date:  2008-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.